OpenAI Researcher Miles Wang Wants $200 Million to Bet on Failed Drugs
OpenAI researcher Miles Wang is in advanced talks to launch an AI drug discovery startup at a $2 billion valuation, with Lightspeed Venture Partners reportedly leading a $200 million round, according …